About
Portfolio
News
Contact
Contact us
Join Us
News
News
2019.05.01
Qpex Biopharma Licenses Polymyxin Antimicrobial Program from Monash University to Address D...
2019.05.01
Qpex Biopharma Licenses Polymyxin Antimicrobial Program from Monash University to Address D...
view more
2019.04.23
NEURELIS ANNOUNCES COMPLETION OF SENIOR MANAGEMENT TE...
2019.04.23
NEURELIS ANNOUNCES COMPLETION OF SENIOR MANAGEMENT TE...
view more
2019.03.29
Chipscreen Biosciences Announces a Collaboration with Innovent to Evaluate Chidamide and the ...
2019.03.29
Chipscreen Biosciences Announces a Collaboration with Innovent to Evaluate Chidamide and the ...
view more
2019.02.21
Neurelis Announces That Intravail® Licensee ARS Pharmaceuticals Intranasal Epinephrine P...
2019.02.21
Neurelis Announces That Intravail® Licensee ARS Pharmaceuticals Intranasal Epinephrine P...
view more
2019.01.31
Neurelis Announces First Product Approved Using The Company’s Intravail® Platform
2019.01.31
Neurelis Announces First Product Approved Using The Company’s Intravail® Platform
view more
2018.10.24
Antibiotics play Qpex launches with Medicines Co. assets, BARDA deal
2018.10.24
Antibiotics play Qpex launches with Medicines Co. assets, BARDA deal
view more
1
2
...
5
6
7
8
9
10
11
12
13
2019.05.01
